Effect of cinnamon essential oil on gut microbiota in the mouse model of dextran sodium sulfate‐induced colitis

Ai‐li Li,Wei‐wei Ni,Qi‐min Zhang,Ying Li,Xin Zhang,Hong‐yan Wu,Peng Du,Jun‐cai Hou,Yun Zhang
DOI: https://doi.org/10.1111/1348-0421.12749
2019-11-26
Microbiology and Immunology
Abstract:Increasing evidence has confirmed that the antimicrobial and anti‐inflammatory effects of cinnamon essential oil (CEO) contribute to protecting against inflammatory bowel disease (IBD). The dextran sodium sulfate (DSS)‐induced colitis mice model was established to investigate the correlation between the protective effects of CEO and the regulation of intestinal microflora. IBD symptoms were assessed by measuring hemoglobin content, myeloperoxidase activity, histopathological observation, cytokines and TLR4 expression. The alteration of fecal microbiome composition was analyzed by 16S rRNA gene sequencing. Results indicated that oral administration of CEO enriched with cinnamaldehyde effectively alleviated the development of DSS‐induced colitis. In contrast to the inability of antibiotics to regulate flora imbalance, the mice fed with CEO improved the diversity and richness of intestinal microbiota, and modified the community composition with a decrease in Helicobacter and Bacteroides and an increase in Bacteroidales_S24‐7 family and SCFA‐producing bacteria (Alloprevotella and Lachnospiraceae_NK4A136_group). Moreover, correlation analysis showed TLR4 and TNF‐α was positively correlated with Helicobacter, but inversely correlated with SCFA‐producing bacteria. These findings indicated from a new perspective that the inhibitory effect of CEO on IBD was closely related to improving the intestinal flora imbalance.This article is protected by copyright. All rights reserved.
immunology,microbiology
What problem does this paper attempt to address?